Richard E. Kuntz

Q: What Schools Are Affiliated With Richard E. Kuntz

Richard E. Kuntz is affiliated with the following schools: Emory University, Utrecht University, Stanford University, University of Alabama at Birmingham

Richard E. Kuntz's AcademicInfluence.com Rankings

Richard E. Kuntz

Philosophy

#8091

World Rank

#11409

Historical Rank

Logic

#5121

World Rank

#6489

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Richard E. Kuntz's Degrees

Masters Business Administration University of Texas at Dallas

Why Is Richard E. Kuntz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard E. Kuntz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. (2003) (4449)
Protected carotid-artery stenting versus endarterectomy in high-risk patients. (2004) (2140)
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting (1998) (1635)
Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials (2001) (909)
ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro (2001) (767)
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary (2001) (728)
Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts (2002) (683)
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. (1999) (676)
Immediate and Late Clinical Outcomes of Carotid Artery Stenting in Patients With Symptomatic and Asymptomatic Carotid Artery Stenosis: A 5-Year Prospective Analysis (2001) (646)
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. (2001) (639)
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). (2004) (632)
Myonecrosis after revascularization procedures. (1998) (572)
Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial: A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis (2004) (553)
Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. (1993) (547)
Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions: Clinical and Angiographic Results of the ENDEAVOR II Trial (2006) (519)
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. (1994) (513)
Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia (2002) (463)
The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. (1994) (445)
Effect of Endothelial Shear Stress on the Progression of Coronary Artery Disease, Vascular Remodeling, and In-Stent Restenosis in Humans: In Vivo 6-Month Follow-Up Study (2003) (436)
Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. (2004) (434)
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. (2002) (432)
Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy (2004) (431)
Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts (2003) (389)
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. (2006) (366)
The Importance of Acute Luminal Diameter in Determining Restenosis After Coronary Atherectomy or Stenting (1992) (354)
Coronary Artery Spatial Distribution of Acute Myocardial Infarction Occlusions (2004) (349)
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. (2000) (311)
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. (2002) (307)
Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience. (1992) (306)
Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials (2004) (303)
Cardiac surgery report cards: comprehensive review and statistical critique. (2001) (294)
Restenosis after Arterial Injury Caused by Coronary Stenting in Patients with Diabetes Mellitus (1993) (288)
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. (2006) (287)
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial (2004) (265)
Novel approach to the analysis of restenosis after the use of three new coronary devices. (1992) (253)
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. (2006) (252)
Defining coronary restenosis. Newer clinical and angiographic paradigms. (1993) (249)
Mechanisms of restenosis and redilation within coronary stents--quantitative angiographic assessment. (1993) (240)
Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) (1998) (231)
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. (2006) (228)
Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison (2005) (199)
Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. (1992) (195)
Regions of low endothelial shear stress are the sites where coronary plaque progresses and vascular remodelling occurs in humans: an in vivo serial study. (2007) (186)
Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS). (2001) (186)
A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. (2005) (174)
Randomized Trial of 90Sr/90Y β-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis (2002) (173)
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. (2006) (170)
Medical Device Development: From Prototype to Regulatory Approval (2004) (165)
Meta-analysis of corticosteroid treatment in acute myocardial infarction. (2003) (162)
Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. (2000) (158)
Quantitative Assessment of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Native Coronary Arteries (2004) (155)
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial. (2005) (152)
IDEAL-D: a rational framework for evaluating and regulating the use of medical devices (2016) (150)
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients (2008) (148)
'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). (1998) (147)
Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study (2000) (143)
First report of the Port Access International Registry. (1999) (141)
Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. (1993) (141)
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. (2002) (140)
Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials (2005) (140)
Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. (1992) (139)
Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. (1994) (139)
Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. (1994) (135)
Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. (1994) (134)
Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. (1994) (134)
Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. (1997) (130)
Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior. (2003) (124)
Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. (2000) (120)
Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. (1996) (119)
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. (2001) (119)
Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis. (1998) (117)
Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents (2005) (117)
A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). (2002) (109)
Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. (1999) (108)
Randomized Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenoses (2000) (107)
Pericardial effusion in patients with cancer: outcome with contemporary management strategies. (1996) (106)
Long-term results of directional coronary atherectomy: predictors of restenosis. (1992) (105)
Impact of Smoking on Clinical and Angiographic Restenosis After Percutaneous Coronary Intervention: Another Smoker’s Paradox? (2001) (101)
Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. (2006) (98)
Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. (2007) (96)
Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study). (2004) (94)
Effects of stent length and lesion length on coronary restenosis. (2004) (93)
Percutaneous treatment of protected and unprotected left main coronary stenoses with new devices: immediate angiographic results and intermediate-term follow-up. (1997) (93)
Prevention of coronary restenosis : the evolving evidence base for radiation therapy. (2000) (93)
Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans (2003) (91)
Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter. (2001) (91)
The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. (2006) (89)
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. (2006) (89)
Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1997) (88)
Zotarolimus (ABT-578) eluting stents. (2006) (88)
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). (2003) (88)
Predictors of event-free survival after balloon aortic valvuloplasty. (1991) (87)
Randomized Trial of 90Sr/90Y &bgr;-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis (2002) (85)
Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents (2004) (83)
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes. (2005) (82)
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. (2005) (82)
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. (2004) (80)
Antithrombotic therapy in patients undergoing coronary angioplasty. (1995) (80)
Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. (2002) (78)
Comparison of PRE-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial). (2001) (77)
Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management, and outcome. (1994) (77)
Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients. (2007) (73)
Impact of Smoking on Health-Related Quality of Life After Percutaneous Coronary Revascularization (2000) (71)
Embolic Protection With Filtering or Occlusion Balloons During Saphenous Vein Graft Stenting Retrieves Identical Volumes and Sizes of Particulate Debris (2004) (69)
Restenosis After Directional Coronary Atherectomy Effects of Luminal Diameter and Deep Wall Excision (1992) (69)
New Frontiers in Interventional Cardiology (2001) (69)
Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. (2005) (68)
Lack of Association Between Migraine Headache and Patent Foramen Ovale: Results of a Case-Control Study (2010) (67)
Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions. (1998) (67)
Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. (2003) (64)
Laser balloon angioplasty: clinical, angiographic and histologic results. (1991) (63)
Acute and long-term outcome of narrowed saphenous venous grafts treated by endoluminal stenting and directional atherectomy. (1992) (61)
Changing incidence and management of abrupt closure following coronary intervention in the new device era. (1992) (61)
Coronary artery stenting in the aged. (2001) (58)
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry. (1999) (58)
Effects of serum lipid levels on restenosis after coronary angioplasty. (1991) (58)
Preintervention arterial remodeling affects clinical outcome following stenting: an intravascular ultrasound study. (2001) (57)
Peripheral directional atherectomy: 4-year experience. (1992) (55)
Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. (1991) (54)
Frequency and consequences of intimal hyperplasia in specimens retrieved by directional atherectomy of native primary coronary artery stenoses and subsequent restenoses. (1993) (54)
Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. (2001) (54)
Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. (2005) (54)
An optimal diagnostic threshold for minimal stent area to predict target lesion revascularization following stent implantation in native coronary lesions. (2001) (54)
Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis. (1993) (53)
Stent jail: a minimum-security prison. (1996) (52)
The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling. (1998) (52)
Overview and experience of the YODA Project with clinical trial data sharing after 5 years (2018) (50)
Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study. (1998) (49)
Risks of coronary artery bypass surgery in dialysis-dependent patients--analysis of the 2001 National Inpatient Sample. (2007) (49)
Does gum chewing ameliorate postoperative ileus? Results of a prospective, randomized, placebo-controlled trial. (2006) (48)
Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). (2007) (48)
Histologic findings in specimens obtained by percutaneous directional coronary atherectomy. (1992) (48)
Comparison of Late Luminal Loss Response Pattern After Sirolimus-Eluting Stent Implantation or Conventional Stenting (2004) (47)
Randomized Trial of 90 Sr / 90 Y-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis (2002) (47)
Treatment of Saphenous Vein Bypass Grafts With Ultrasound Thrombolysis: A Randomized Study (ATLAS) (2003) (47)
Transcatheter valve therapy registry is a model for medical device innovation and surveillance. (2015) (46)
Rheolytic thrombectomy with the Possis AngioJet: technical considerations and initial clinical experience. (1999) (44)
A Predictive Method for Estimating the Late Angiographic Results of Coronary Intervention Despite Incomplete Ascertainment (1993) (42)
Short- and Intermediate-Term Clinical Outcomes From Direct Myocardial Laser Revascularization Guided by Biosense Left Ventricular Electromechanical Mapping (2000) (41)
Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. (2002) (41)
Influence of vessel selection on the observed restenosis rate after endoluminal stenting or directional atherectomy. (1992) (40)
Quantitative coronary angiographic and intravascular ultrasound assessment of a new nonarticulated stent: report from the Advanced Cardiovascular Systems MultiLink stent pilot study. (1998) (38)
Remodeling characteristics of minimally diseased coronary arteries are consistent along the length of the artery. (2006) (37)
Network News: Powering Clinical Research (2013) (37)
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. (2004) (37)
Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris. (2001) (36)
Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial. (2006) (36)
New Frontiers in Interventional Cardiology: Intravascular Radiation to Prevent Restenosis (2001) (35)
Post–Market Approval Surveillance: A Call for a More Integrated and Comprehensive Approach (2004) (35)
The reporting of blinding in physical medicine and rehabilitation randomized controlled trials: a systematic review. (2013) (35)
Cost-Effectiveness of Gamma Radiation for Treatment of In-Stent Restenosis: Results From the Gamma-1 Trial (2002) (35)
Coronary Revascularization after Myocardial Infarction in the Very Elderly: Outcomes and Long-Term Follow-up (1993) (35)
Endoluminal stenting of a subclavian artery stenosis to treat ischemia in the distribution of a patent left internal mammary graft. (1994) (34)
Technical feasibility , safety , and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing (34)
Defining Coronary Restenosis (2005) (34)
Application of models for multivariate mixed outcomes to medical device trials: coronary artery stenting (2002) (33)
ACC/AHA 2007 methodology for the development of clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. (2007) (33)
Internal mammary angiography: a review of technical issues and newer methods. (1990) (32)
Multivessel Palmaz-Schatz stenting: early results and one-year outcome. (1997) (31)
Do excimer laser angioplasty and rotational atherectomy facilitate balloon angioplasty? Implications for lesion-specific coronary intervention. (1996) (31)
Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant? (1994) (31)
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial). (2002) (31)
Cost-effectiveness of sirolimus drug-eluting stents for the treatment of complex coronary stenoses: Results from the randomized SIRIUS trial (2003) (30)
Effect of gender on in-hospital and one-year outcomes after contemporary coronary artery stenting. (2005) (30)
Feasibility Trial of Carotid Stenting with and without an Embolus Protection Device (2005) (30)
Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: Results from the multicenter X‐sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X‐TRACT) study (2003) (30)
Right ventricular infarction complicated by acute right-to-left shunting. (1994) (29)
Effect of prior coronary restenosis on the risk of subsequent restenosis after stent placement or directional atherectomy. (1994) (29)
Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. (2006) (29)
Analysis of late lumen narrowing after excimer laser-facilitated coronary angioplasty. (1994) (28)
Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry. (2007) (28)
A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease. (2002) (24)
Directional coronary atherectomy: how much lumen enlargement is optimal? (1993) (24)
Recurrent reversible cardiogenic shock triggered by emotional distress with no obstructive coronary disease. (1995) (22)
Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: a model for protection from acute myocardial infarction. (2010) (22)
Treatment of coronary stent thrombosis with rheolytic thrombectomy: Results from a multicenter experience (2003) (21)
Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis (2005) (21)
Early ostial vein graft stenosis: management by atherectomy. (1991) (21)
Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection (2006) (21)
Relationship between plaque mass and neointimal hyperplasia after stent placement in Yucatan micropigs. (1997) (21)
Investigational use of the Palmaz-Schatz biliary stent in large saphenous vein grafts. (1993) (21)
Location of acute coronary artery thromboses in patients with and without chronic kidney disease. (2009) (20)
CABG after successful PTCA: a case-control study. (1995) (20)
Preliminary experience with the POSSIS coronary AngioJet rheolytic thrombectomy catheter in the VeGAS I pilot study (1996) (20)
Frequency and outcome of chest pain after two new coronary interventions (atherectomy and stenting). (1992) (19)
Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial. (2001) (18)
The SIRIUS‐DIRECT trial: A multi‐center study of direct stenting using the sirolimus‐eluting stent in patients with de novo native coronary artery lesions (2007) (18)
At the Intersection of Health, Health Care and Policy (2014) (17)
Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection. (2004) (17)
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis. (2002) (17)
Coronary drug-eluting stent development: issues in trial design. (2005) (16)
Predictors of CABG within one year of successful PTCA: a retrospective, case-control study. (1997) (16)
Understanding the drug-eluting stent trials. (2007) (16)
Acute and long‐term results of coronary stents and atherectomy in women and the elderly (1995) (16)
The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial). (2006) (16)
SAMPLE SIZE CALCULATION FOR A HISTORICALLY CONTROLLED CLINICAL TRIAL WITH ADJUSTMENT FOR COVARIATES (2002) (15)
Cardiogenic shock induced by cocaine in swine with normal coronary arteries. (1994) (15)
Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials (2000) (15)
Incidence and predictors of late total occlusion following coronary stenting (2003) (14)
Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial. (2006) (14)
Modeling the impact of patient and lesion characteristics on the cost-effectiveness of drug-eluting stents (2003) (14)
Problems in the evaluation of new devices for coronary intervention: what have we learned since 1989? (1997) (14)
Risk assessment for percutaneous coronary intervention: our version of the weather report? (2003) (12)
Acute results of directional coronary atherectomy in the Balloon Versus Optimal Atherectomy Trial (BOAT) pilot phase. (1996) (12)
Humanitarian Use Devices/Humanitarian Device Exemptions in cardiovascular medicine. (2005) (12)
One-year follow-up of the SIRIUS study: A randomized study with the sirolimus-eluting Bx VELOCITY in the treatment of patients with denovo native coronary artery lesions (2003) (12)
Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy). (2007) (12)
CRUISE: can routine intravascular ultrasound influence stent expansion? Analysis of outcomes (1998) (11)
The Changing Structure of Industry-Sponsored Clinical Research: Pioneering Data Sharing and Transparency (2013) (11)
A meta-analysis of randomized controlled trials of intracoronary gamma- and beta-radiation therapy for in-stent restenosis (2006) (11)
Comparative analysis of early and late angiographic outcomes using two quantitative algorithms in the Balloon versus Optimal Atherectomy Trial (BOAT). (1999) (10)
984-27 Arterial Remodeling Contributes to Restenosis After Angioplasty, but is Prevented by Stenting in the Atherosclerotic Micropig (1995) (10)
Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter–defibrillators (2017) (10)
Measuring percutaneous coronary intervention quality by simple case volume. (2005) (10)
Coronary angioplasty. Is surgical standby needed? (1992) (10)
Appropriate uses of angiographic follow-up in the evaluation of new technologies for coronary intervention. (1994) (10)
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Authors' reply (2005) (9)
Early and late quantitative angiographic outcomes in the optimal atherectomy restenosis study (OARS) (1996) (9)
Immediate results and long-term follow-up after repeat balloon aortic valvuloplasty. (1992) (9)
Restenosis following new coronary devices: The influence of post-procedure luminal diameter (1991) (9)
Percutaneous occlusion of an iatrogenic aortosaphenous vein--coronary vein fistula via retrograde coronary sinus approach. (1996) (9)
The effect of intracoronary fibroblast growth factor‐2 on restenosis after primary angioplasty or stent placement in a pig model of atherosclerosis (2002) (9)
Is an aggressive rotablator strategy preferable to a standard rotablator strategy in patients with heavily calcified coronary lesions? a report from the STRATAS trial (1998) (8)
Data Acquisition, Curation, and Use For a Continuously Learning Health System: A Vital Direction for Health and Health Care (2016) (8)
Balloon postdilation can safely improve the results of successful (but suboptimal) directional coronary atherectomy. (1993) (8)
Intracardiac thrombus causing peritoneovenous shunt failure: detection by two-dimensional echocardiography. (1986) (8)
Chronic Myocardial Ischemia Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Phase 1 / 2 Placebo-Controlled , Double-Blind , Dose-Escalating Trial of Myocardial Vascular (2002) (8)
Six-month clinical and angiographic results of the SMART trial (1998) (8)
Antithrombotic therapy in patients undergoing coronary angioplasty. (1998) (8)
Remodeling after PTCA: from shrinkage to compensatory enlargement. (1995) (8)
The impact of sirolimus-eluting stents in diabetics: Results from the SIRIUS trial (2003) (7)
ACC/AHA 2007 methodology for the development of clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. (2007) (7)
Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes. (2003) (7)
862-1 Matched comparison of direct stenting to predilation with the sirolimus-eluting by velocity™ stent (2004) (7)
Rotational atherectomy for the treatment of restenotic ostial side branches jailed by prior stent placement. (1998) (7)
Mechanical thrombectomy using the angiojet catheter in the treatment of acute myocardial infarction (1998) (7)
Percutaneous coronary intervention-induced emboli during primary PCI for STEMI: too little, too much, or too late? (2005) (6)
902-4 Intravascular Ultrasound Analysis of Routine High Pressure Balloon Post-Dilatation After Palmaz-Schatz Stent Deployment (1995) (6)
Late quantitative angiographic results after NIR stent use: results from the NIRVANA randomized trial end registries (1998) (5)
Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting. (2006) (5)
Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis. (2005) (5)
730-2 Acute Angiographic, Intravascular Ultrasound and Clinical Results of Directional Atherectomy in the Optimal Atherectomy Restenosis Study (1995) (5)
Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing. (2019) (5)
Managing the embolization problem during saphenous vein graft intervention (1999) (5)
Aortic valvuloplasty. (1991) (4)
Feasibility of directional atherectomy for the treatment of bifurcation lesions (1992) (4)
Mechanism of luminal enlargement by optimal atherectomy — IVUS insights from the OARS study (1996) (4)
The effect of institutional experience on the outcome of primary angioplasty for acute MI (1996) (4)
Pursuit of large lumen dimensions after coronary intervention {editorial}. (1993) (4)
Influence of routine angiographic follow-up on clinical restenosis outcome in the ASCENT trial (1998) (4)
Myocardial Infarction After Rotational Atherectomy: Predictors and Influence on Late Outcome in the STRATAS Trial (1998) (4)
Balloon angioplasty versus debulking for treatment of diffuse in-stent restenosis (1998) (4)
Extravasation of thrombus into the aortic root: a complication following use of an infusion catheter for intragraft thrombolysis. (1996) (4)
Clinical outcomes and dose analysis of the effect of beta radiation for the management of in stent restenosis: Results of the stents and radiation therapy (START) randomized trial (2000) (4)
Efficacy of Sr-90 beta radiation for the treatment of in-stent restenosis: 24-month clinical outcomes from the STents and Radiation Therapy Trial (START) (2002) (4)
Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data (2020) (3)
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site. (2011) (3)
The clinical impact of sidebranch occlusion and sidebranch narrowing after elective coronary stent placement in STARS (1998) (3)
1022-82 A prospective, randomized trial of mild hypothermia during primary percutaneous intervention for acute myocardial infarction (COOL-MI): One-year clinical outcome (2004) (3)
709-4 Intraaortic Balloon Pump Counterpulsation in Octogenarians: Outcome and Complications (1995) (3)
A comparison of the long AVE micro™ Stent II and the Palmaz-Schatz stent: a SMART trial registry (1998) (3)
Cocaine-induced transmural myocardial infarction in a Yorkshire swine with normal coronary arteries: Evidence for microvascular and/or epicardial coronary artery spasm. (1994) (3)
Advancing the Science of Healthcare Service Delivery: The NHLBI Corporate Healthcare Leaders' Panel. (2018) (3)
From Prototype to Regulatory Approval (2004) (3)
An evidence-based approach to the use of drug-eluting stents in clinical practice. (2004) (3)
Endothelial shear stress identified in vivo within the stent is related to in-stent restenosis and remodeling of stented coronary arteries (2002) (3)
Predictors of clinical and angiographic restenosis in the Sirolimus-Eluting Bx VELOCITY stent trial (2003) (2)
Prediction of sites of progression of native coronary disease in-vivo based on identification of sites of low endothelial shear stress (2002) (2)
1003-94 Rheolytic thrombectomy for the treatment of acute myocardial infarction in patients with angiographic large thrombus burden: One-year results of the VeGAS 2 acute myocardial infarction registry (2004) (2)
Interprocedural interval as a risk factor for recurrent restenosis after treatment of in-stent restenosis: differential response with and without brachytherapy (2002) (2)
Distal Protection Devices During Percutaneous Saphenous Vein Graft Intervention: Has a New Standard of Care Been Established? (2001) (2)
Effect of baseline thrombus in the SAFER (saphenous vein graft angioplasty free of emboli randomized) trial (2002) (2)
Endeavor II Three-Year Clinical Results: A Randomised, Double-Blind, Multicentre Trial of the Endeavor Zotarolimus-Eluting Stent for Treatment of Native Coronary Arteries (2007) (2)
Routine High Pressure Post-stent Dilatation did Not Influence Clinical Restenosis in STARS (1998) (2)
Multivessel coronary intervention with a balloon‐expandable intracoronary stent (1992) (2)
Is there a role for strip chart recording to guide rotational atherectomy? Initial findings from stratas (1996) (2)
A prospective randomized multicenter trial comparing distal protection during saphenous vein graft intervention with a filter-based device compared to balloon occlusion and aspiration: The FIRE trial (2003) (2)
Application of a continuous regression model of restenosis to saphenous vein grafts after successful percutaneous transluminal coronary angioplasty or directional coronary atherectomy. (2000) (2)
In-vivo prediction of outward remodeling in native portions of stented coronary arteries associated with sites of high endothelial shear stress at the time of deployment (2002) (2)
Cost-effectiveness of abciximab after coronary stenting: a decision-analytic model (1998) (2)
Immediate and Late Clinical Outcomes of Carotid Angioplasty and Stenting in Patients with Symptomatic and Asymptomatic Carotid ery nosis: A Five-Year Prospective Analysis (2004) (2)
The advantage of d-sotalol over dl-sotalol in a patient with ventricular arrhythmias and comorbid bronchospasm. (1992) (2)
Parallel Hypothesis Testing for Science and Industry in a Large Randomized Clinical Trial (2001) (2)
Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators (2018) (1)
in-vivo evaluation of a Novel ePTFE-covered self-expanding stent for the treatment of diseased saphenous vein bypass grafts (2002) (1)
A prospective, randomized trial of thromboatherectomy during intervention of thrombotic native coronary arteries and saphenous vein grafts: The X-TRACT trial (2003) (1)
Intravascular Radiation to Prevent Restenosis (2001) (1)
ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Perc (2016) (1)
Does the beneficial effect of distal protection in saphenous vein graft interventions vary with lesion length? A SAFER (Saphenous Vein Graft Angioplasty Free of Emboli Randomized) substudy (2002) (1)
The Pleiotropic Effects of Statins : Fact or Fantasy ? (1)
Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern". (2007) (1)
Angiographic indicators for the use of distal protection devices in saphenous vein graft interventions (2002) (1)
Balloon aortic valvuloplasty in perspective (1990) (1)
[Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study]. (1996) (1)
Progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans as a function of endothelial shear stress: An In-Vivosix-month follow-up study (2003) (1)
Aging of intracoronary thrombus due to delayed time-to-reperfusionsincreases ischemic and angiographic complications in acute myocardial infarction (2002) (1)
Late angiographic assessment of the edge effect and restenosis associated with intraluminal sonotherapy: results from the SILENT (Sonotherapy for In-Lesion Elimination of Neointimal Tissue) trial (2002) (1)
Evaluation of Restenosis Following New Coronary Interventions (1992) (1)
Gamma vascular brachytherapy neutralizes the negative impact of diabetes mellitus on clinical outcomes after PCI for in-stent restenosis: pooled data from Gamma I, Gamma II, and SCRIPPS III trials (2002) (0)
Thirty day and six month results of a multicenter randomized trial comparing distal protection with a filter-based catheter to balloon occlusion and aspiration during percutaneous intervention of saphenous vein bypass grafts the fire trial (2003) (0)
Clinical and Angiographic Characteristics of 236 Coronary Segments Treated by Coronary Atherectomy or Stenting Patients (2005) (0)
Teirstein and Kuntz Intravascular Radiation to Prevent Restenosis 2621 (2001) (0)
‘Optimal’ Directional Coronary Atherectomy (1998) (0)
Long term clinical follow up of the phase III randomized trial (START) evaluating the role of beta radiation for the treatment of in stent restenosis (2004) (0)
Investigational Use of the Saphenous Vein Grafts (1992) (0)
Right Ventricular Infarction Complicated by Acute Right-WLeft Shunting (1994) (0)
Coronary Remodeling andInterventional Strategies (1997) (0)
Analysis of clinical outcomes from the START and START 40 trials: the efficacy of SR-90 radiation in the treatment of long lesion in stent restenosis (2001) (0)
Two-year clinical follow-up of Sr/Y h-radiation versus placebo control for the treatment of in-stent restenosis (2005) (0)
Angiographic Follow-up According to Device Type and Elective Versus Nonelective Stratification Overall Stents Atherectomy (2005) (0)
Current Shocks and Prevents Left Ventricuiar Dysfunction in an In Vivo Swine Model (2002) (0)
Multivessel palmaz-schatz stenting: Acute results and long-term outcome (1996) (0)
Capnography: Clinical Aspects (2006) (0)
omparison of Zotarolimus-Eluting nd Sirolimus-Eluting Stents in Patients ith Native Coronary Artery Disease Randomized Controlled Trial avid (2006) (0)
Coronary Slanting During Acute Myocardial Infarction. Results From the Stent Without (1996) (0)
Coronary Intervention (2005) (0)
Reproducibility of three-dimensional lumen, plaque, and outer vessel reconstructions and of endothelial shear stress measurements in vivo to determine progression of atherosclerosis (2002) (0)
Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions Clinical and Angiographic Results of the ENDEAVOR II Trial Interventional Cardiology (2006) (0)
LINKING THE NCDR CATHPCI REGISTRY WITH ADMINISTRATIVE CLAIMS TO DETERMINE ATTRIBUTION OF REPEAT REVASCULARIZATION FOLLOWING INDEX DRUG-ELUTING STENT IMPLANTATION (2019) (0)
Identification of “plaque-free” reference segments using standard quantitative angiography (1996) (0)
Thrombus Causing Peritoneovenous Shunt Failure : Detection by Two-Dimensional Echocardiography (2010) (0)
Long-Term Outcome of Patients Treated With Repeat Percutaneous Coronary Intervention After Failure of &ggr;-Brachytherapy for the Treatment of In-Stent Restenosis (2002) (0)
urrogates , Substudies , and Real Clinical nd Points in Trials of Drug-Eluting Stents (0)
Abstract 1680: Spatial Distribution of Myocardial Infarction in Patients with Diabetes Mellitus (2007) (0)
Quantitative angiographic findings of the PREDICT trial: a randomized clinical trial comparing a strategy of predilatation prior to stent placement versus direct stenting (2002) (0)
Coronary Atherectomy , Atheroablation , and Thrombectomy * (2000) (0)
Left main artery Left anterior descending coronary artery Circumflex artery Right coronary artery Prior restenosis Immediate results (2005) (0)
1024-47 Sirolimus versus plain old balloon angioplasty small vessels (2004) (0)
Smooth muscle cell proliferation, growth and migration in primary and restenotic human coronary atherosclerotic tissue (1996) (0)
Validation of Lesion‐Based Restenosis Analysis: Lesion‐to‐Lesion Independence of Restenosis After Treatment by Conventional Angioplasty, Stenting, or Directional Atherectomy (1993) (0)
1121-56 Earlier time to restenosis predicts outcomes following gamma vascular brachytherapy (2004) (0)
Sr/Y -Radiation Versus Placebo Control for Treatment of In-Stent Restenosis (2002) (0)
Abstract 5451: Coronary Spatial Distribution of Non-ST Elevation Myocardial Infarction is Non-Uniform and Clustered in the Proximal Portion of the Coronary Tree (2009) (0)
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. (2006) (0)
Mortality Risk of Postprocedural reatine Kinase-MB Elevation Following uccessful Versus Unsuccessful Stent Procedures (2016) (0)
Long-Term Outcome of Patients Treated With Repeat Percutaneous Coronary Intervention After Failure of -Brachytherapy for the Treatment of In-Stent Restenosis (2002) (0)
Response to Letters Regarding Article, “Lack of Association Between Migraine Headache and Patent Foramen Ovale: Results of a Case-Control Study” (2010) (0)
Restenosis, statistics, and reasonable inferences. Authors' replay (2006) (0)
Perfusion therapy to reduce myocardial ischemia en route to emergency coronary artery bypass grafting for failed percutaneous transluminal coronary angioplasty. (1995) (0)
An optimal acute result after directional atherectomy or stent placement reduces the risk of subsequent restenosis. (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard E. Kuntz?

Richard E. Kuntz is affiliated with the following schools: